Topic: regenerative medicine
The FDA has shot down Enzyvant's RVT-802, a rare immunodeficiency disease candidate, citing manufacturing concerns.
Biostage’s replacement esophagus received an FDA clinical hold as the company works to field questions from the agency ahead of clinical studies.
Harnessing macrophages that provide healing in response to inflammation could be a better approach to treating heart attack than stem cells have been.
Tokyo-based Heartseed has raised 2.8 billion yen, or about $26 million U.S., to help develop its stem cell-based treatment for heart failure.
Scientists used machine learning and CRISPR-Cas9 to control the patterns iPSCs form in lab dishes, an important step to create functional organs.
With a multipronged approach and a fresh infusion of $92 million, Tenaya Therapeutics is going after the underlying causes of heart disease.
A Penn team is adapting CAR-T cell therapy to target cardiac fibrosis, and they have promising early results in rodents.
A revised flavonoid could promote the regrowth of functional myelin in mice, scientists at the Oregon Health & Science University have shown.
A self-assembling peptide hydrogel developed by the New Jersey Institute of Technology improved neuronal survival in rats with traumatic brain injury.
A Stanford team has proposed a strategy for coaxing supporting cells in the brain to transform into memory-preserving neurons.